MILC Application for Exclusive Breastfeeding
(MILC Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are taking antiretroviral medication, chemotherapy agents, or any prescription drugs that are incompatible with breastfeeding.
What data supports the effectiveness of the MILC Application treatment for exclusive breastfeeding?
Is the MILC Application for Exclusive Breastfeeding safe for humans?
There is no specific safety data available for the MILC Application for Exclusive Breastfeeding. However, related studies on breastfeeding devices and medications used during lactation highlight the importance of monitoring for potential adverse events, such as pain or infection, and ensuring safe use.678910
How does the MILC Application treatment for exclusive breastfeeding differ from other treatments?
The MILC Application treatment is unique because it focuses on supporting exclusive breastfeeding through a digital application, which may offer personalized guidance and support to mothers, potentially addressing challenges in establishing and maintaining exclusive breastfeeding. This approach differs from traditional methods that rely on in-person support or educational materials.1112131415
What is the purpose of this trial?
The innovative platform MILC is designed to provide an integrated and comprehensive professional and social support network with personalized breastfeeding (BF) education to target exclusive breastfeeding (EBF) and any BF behaviors in low-income Hispanic women. Formative research conducted for the development of MILC and results from pilot testing will help guide the completion of the development and testing of this prototype that specifically caters to Hispanic women. In the long term, MILC has the potential to increase the rates of EBF and any BF up to 12 months.
Research Team
Tony Ma, MS
Principal Investigator
Benten Technologies
Yukiko Washio, PhD
Principal Investigator
RTI International
Eligibility Criteria
This trial is for low-income Hispanic mothers who are currently breastfeeding or planning to breastfeed. It aims to help them overcome breastfeeding challenges using a mobile app called MILC, which offers professional and social support along with personalized education.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the MILC application along with standard WIC services
Follow-up
Participants are monitored for breastfeeding rates and app usability
Treatment Details
Interventions
- MILC Application
Find a Clinic Near You
Who Is Running the Clinical Trial?
Benten Technologies, Inc.
Lead Sponsor
Temple University
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD)
Collaborator
UConn Health
Collaborator
RTI International
Collaborator